SHIP negatively regulates IgE + antigen-induced IL-6 production in mast cells by inhibiting NF-κB activity

Journal of Immunology

Volumn 168, Issue 9, 2002, Pages 4737-4746

  Kalesnikoff, Janet ^a   Baur, Nicole ^a   Leitges, Michael ^a   Hughes, Michael R ^a   Damen, Jacqueline E ^a   Huber, Michael ^a   Krystal, Gerald ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; I KAPPA B; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN SHIP; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION REGULATION; IMMUNOREGULATION; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSACTIVATION;

EID: 0036569406     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.9.4737     Document Type: Article

References (67)

1. Mast cells as sentinels of innate immunity
2. Mast cells: Function and contents
3. Mast cells and basophils
4. Mast cells in innate immunity
5. Signalling through the high-affinity IgE receptor Fcε RI
6. Signal transduction by Fc receptors: The Fcε R1 case
7. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation
8. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase
9. Structure, function, and biology of SHIP proteins
10. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling
11. PKB/Akt: Connecting phosphoinositide 3-kinase to cell survival and beyond
12. SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival
13. SHIP modulates immune receptor responses by regulating membrane association of Btk
14. Rottlerin-independent attenuation of pervanadate-induced tyrosine phosphorylation events by protein kinase C-δ in hemopoietic cells
15. 3 and inhibition of mast cell degranulation
16. Thapsigargin-induced degranulation of mast cells is dependent on transient activation of phosphatidylinositol 3-kinase
17. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs
18. Lyn is required for normal stem cell factor-induced proliferation and chemotaxis of primary hematopoietic cells
19. Dependence of mast cell IgE-mediated cytokine production on nuclear factor-κB activity
20. dok is a mediator of inhibitory FcγRIIB signals in B cells
21. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B
22. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα
23. Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site
24. How BAD phosphorylation is good for survival
25. Regulation of protein kinase ζ by P1 3-kinase, and PDK-1
26. Activation of protein kinase C by phosphatidylinositol 3,4,5- trisphosphate
27. Further evidence that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is required for the stability and phosphorylation of protein kinase C (PKC) isoforms
28. Intracellular signalling: PDK1 - A kinase at the hub of things
29. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1
30. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C
31. Localization of protein kinases by anchoring proteins: A theme in signal transduction
32. Regulation of receptor-mediated protein kinase C membrane trafficking by autophosphorylation
33. Protein kinase C-mediated serine phosphorylation directly activates Raf-1 in murine hematopoietic cells
34. Akt stimulates the transactivation potential of the Rel A/p65 subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38
35. Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells
36. Protein kinase C-δ regulates thrombin-induced 1CAM-1 gene expression in endothelial cells via activation of p38 mitogen-activated protein kinase
37. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway
38. Inhibition of degranulation and interleukin-6 production in mast cells derived from mice deficient in protein kinase Cβ
39. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for Iκβ phosphorylation and NF-κB activation
40. The Rel/NF-κB signal transduction pathway: Introduction
41. Tumor suppressor MMAC/PTEN inhibits cytokine-induced NFκB activation without interfering with the IκB degradation pathway
42. Bridging the gap: Composition, regulation, and physiological function of the IκB kinase complex
43. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo
44. Two waves of nuclear factor κB recruitment to target promoters
45. SHIP represses mast cell activation and reveals that IgE alone triggers signalling pathways which enhance normal mast cell survival
46. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival
47. Dual regulation of platelet protein kinase B
48. Activation of transcription factor NF-κB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways
49. The phosphatidylinositol 3-kinase inhibitor wortmannin blocks mast cell exocytosis but not IL-6 production
50. An inhibitor of P13-K differentially affects proliferation and IL-6 protein secretion in normal and leukemic myeloid cells depending on the stage of differentiation
51. Secretion of TNF from a rat mast cell line is a brefeldin A-sensitive and a calcium/protein kinase C-regulated process
52. Studies of different aspects of the role of protein kinase C in mast cells
53. IL-9 and 1L-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-κB is decisively involved in the expression of IL-9
54. Akt-dependent cytokine production in mast cells
55. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-κB
56. Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma
57. Induction of NF-κB by the Akt/PKB kinase
58. NF-κB is a target of AKT in anti-apoptotic PDGF signalling
59. NF-κB activation by turnout necrosis factor requires the Akt serine-threonine kinase
60. Phosphatidylinositol 3-kinase in interleukin 1 signaling: Physical interaction with the interleukin 1 receptor and requirement in NFκB and AP-I activation
61. The PTEN tumor suppressor protein inhibits tumor necrosis factor-induced nuclear factor κB activity
62. Activation of IκB kinase β by protein kinase C isoforms
63. Protein kinase C-θ participates in NF-κB activation induced by CD3-CD28 costimulation through selective activation of IκB kinase β
64. The p38 mitogen-activated protein kinase is required for NF-κB dependent gene expression: The role of TATA-binding protein (TBP)
65. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor
66. Duration of nuclear NF-κB action regulated by reversible acetylation
67. Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6